Skip to content
Healthcare Industry News, Trends & Articles

Press release

The global market for virtual reality therapy in chronic obstructive pulmonary disease is entering a period of growth.

TBThe Business Research Company5 min read

Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Report 2026

Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Report 2026

The Business Research Company

The Business Research Company

The Business Research Company’s chronic obstructive pulmonary disease Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 18, 2026 /EINPresswire.com/ -- The use of virtual reality in healthcare is transforming treatment options for chronic respiratory conditions, especially Chronic Obstructive Pulmonary Disease (COPD). This innovative approach is drawing attention for its potential to improve patient outcomes through immersive therapy experiences. Below, we explore the current market status, growth factors, leading regions, and emerging trends in the COPD virtual reality therapy market.

Rapid Expansion of the Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market
The market size for COPD virtual reality therapy has experienced swift growth recently, rising from $1.38 billion in 2025 to an anticipated $1.65 billion in 2026, supported by a strong compound annual growth rate (CAGR) of 19.5%. This upward trend during the past years is mainly driven by the expansion of pulmonary rehabilitation programs, the increasing prevalence of COPD worldwide, broader acceptance of non-pharmacological treatment options, advancements in digital health platforms, and greater availability of VR hardware in clinical environments.

Download a free sample of the chronic obstructive pulmonary disease virtual reality therapy market report:
https://thebusinessresearchcompany.com/sample_request?id=97090974&type=smp&name=Chronic%20Obstructive%20Pulmonary%20Disease%20Virtual%20Reality%20Therapy%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Forecasted Growth Trajectory of the COPD Virtual Reality Therapy Market
Looking ahead, the COPD virtual reality therapy market is projected to continue its accelerated growth, reaching $3.33 billion by 2030 with a CAGR of 19.3%. This forecasted surge is fueled by a rising demand for remote respiratory care, increased investments in immersive digital therapeutics, growth in homecare pulmonary management programs, the integration of AI-driven personalized therapies, and a stronger focus on improving patient adherence and engagement. Key trends expected to shape this market include wider adoption of home-based VR pulmonary therapy, incorporation of gamified rehabilitation modules, expanded use of remote patient monitoring technologies, development of immersive respiratory training tools, and enhanced emphasis on patient involvement.

Understanding COPD Virtual Reality Therapy and Its Applications
Chronic obstructive pulmonary disease virtual reality therapy is a non-drug treatment method that uses immersive virtual environments to assist patients with respiratory rehabilitation. This approach combines interactive exercises, breathing techniques, and real-time feedback to help manage symptoms and improve lung function while promoting greater patient engagement. VR therapy is increasingly being incorporated into digital health platforms, supporting both clinical and home-based pulmonary care.

View the full chronic obstructive pulmonary disease virtual reality therapy market report:
https://thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-virtual-reality-therapy-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Growing Awareness and Acceptance as a Market Growth Catalyst
The expanding awareness and acceptance of virtual reality therapy are pivotal factors propelling the growth of the COPD virtual reality therapy market. VR therapy leverages immersive technology to create interactive treatment environments that offer pain relief and anxiety reduction without relying on pharmaceuticals. This drug-free, non-invasive option enhances patient experience and treatment effectiveness. Increased familiarity among patients and healthcare providers with VR therapy fosters higher adoption rates of digital rehabilitation solutions, encouraging better patient compliance and improved health outcomes. For example, in July 2024, the U.S. Department of Veterans Affairs reported deploying approximately 3,500 VR headsets across more than 170 VA medical centers and clinics, tripling the availability of VR devices for therapeutic use.

Personalized Medicine’s Role in Accelerating COPD VR Therapy Market Growth
An increasing focus on personalized medicine is also driving the expansion of the COPD virtual reality therapy market. Personalized medicine tailors treatment plans to individual genetic profiles, lifestyles, and environmental factors to optimize healthcare outcomes. Advances in genomics have made it possible to identify precise genetic variations, enabling customized treatment strategies. In COPD VR therapy, this approach allows for immersive rehabilitation programs that are finely tuned to the unique needs of each patient, improving effectiveness and encouraging greater participation. For instance, data from February 2024 show that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable jump from 12 approvals in 2022, reflecting rapid progress in personalized healthcare development.

Regional Leadership and Emerging Markets in COPD Virtual Reality Therapy
In 2025, North America held the largest share of the COPD virtual reality therapy market, establishing itself as the leading regional market. Meanwhile, the Asia-Pacific region is positioned to be the fastest-growing area throughout the forecast period. The market report encompasses a broad range of regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive view of regional market dynamics and growth prospects.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.